Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Bringing the PRO to fruition

May 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PROs, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …
Feature
shutterstock_273326141

Medigene and bluebird bio expand immunotherapy partnership to $1.5bn

May 14, 2018 Research and Development, Sales and Marketing Bluebird Bio, Cancer, Medigene, pharma

Medigene has announced that it has bolstered the existing partnership it has in place with US firm bluebird bio, originally …
News
webinar

Free webinar: EU risk management for oncology medicines

May 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, dia

News
david_horn_solomon

Akari CEO resigns over allegations of spending company funds

May 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, appointment

Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit …
Appointment
top_ten

Top Ten most popular articles on Pharmafile.com this week

May 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical

It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …
News
roche

Roche’s Tecentriq/Cotellic combo therapy fails to impress in colorectal cancer

May 11, 2018 Medical Communications, Research and Development Cancer, Cotellic, Roche, pharma, tecentriq

Roche has been rocked by a Phase 3 weak showing from its combination Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people …
News

AZ’s Fasenra stumbles in P3 for COPD

May 11, 2018 Medical Communications, Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical

AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up …
News
andy_c4

C4 Therapeutics fills out C-Suite with CEO appointment

May 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing C4 Therapeutics, biotech, drugs, pharma, pharmaceutical

C4 Therapeutics has been slowly expanding since its creation in early 2016 out of the prestigious Dana-Farber Cancer Institute. Andrew …
Appointment
cancer-vs-alzheimer-1080x810

NanoBots: The science of small to dwarf the disease

May 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Precision Medicine, nanorobots, pharma

Anjali Shukla delves into the exciting, miniature world of nanorobotics to explore how the ground-breaking technology promises to change the …
Feature
pharmafile_srping_2018_cover

The new and improved Spring 2018 edition of Pharmafile is available to read online now!

May 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CNS, Cancer, Pharmafocus, cardiovascular, cvd, oncology, pharmafile

The Spring 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …
News
joanna_shields

BenevolentAI names former UK Minister as new Group CEO

May 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, BenevolentAI, Facebook, UK, appointment, google

Health and drug development-focused artificial intelligence firm BenevolentAI has announced that former UK Minister for Internet Security and Safety Joanna …
Appointment
valeant_web

Valeant seeks clean slate with rebrand, new company name

May 9, 2018 Medical Communications, Research and Development Valeant, pharma

In the latest attempt to reverse its ailing fortunes and distance itself from its polluted brand, Canadian pharma firm Valeant …
News
bald_man

Old osteoporosis drug could be used to treat hair loss

May 9, 2018 Research and Development biotech, drugs, hair loss, pharma, pharmaceutical

Researchers from the University of Manchester’s Centre for Dermatology Research have made a breakthrough towards the holy grail of the …
News
faron_share

Faron’s stock freefalls by 80% after key drug failure

May 9, 2018 Research and Development ARDS, Faron, acute respiratory distress syndrome, pharma, traumakine

Faron Pharmaceuticals has seen its share price plummet by more than 80% after it emerged that its recombinant human interferon …
News
michael_cohen

Novartis caught in the Stormy Daniels affair, after huge payment to Trump’s lawyer

May 9, 2018 Medical Communications, Research and Development Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025